Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Assets Average (2018 - 2025)

Arcus Biosciences has reported Assets Average over the past 8 years, most recently at $1.1 billion for Q4 2025.

  • Quarterly results put Assets Average at $1.1 billion for Q4 2025, down 13.76% from a year ago — trailing twelve months through Dec 2025 was $1.1 billion (down 13.76% YoY), and the annual figure for FY2025 was $1.1 billion, up 1.96%.
  • Assets Average for Q4 2025 was $1.1 billion at Arcus Biosciences, up from $1.0 billion in the prior quarter.
  • Over the last five years, Assets Average for RCUS hit a ceiling of $1.6 billion in Q1 2022 and a floor of $853.7 million in Q1 2021.
  • Median Assets Average over the past 5 years was $1.2 billion (2021), compared with a mean of $1.2 billion.
  • Biggest five-year swings in Assets Average: surged 350.2% in 2021 and later decreased 18.54% in 2023.
  • Arcus Biosciences' Assets Average stood at $1.2 billion in 2021, then grew by 10.8% to $1.3 billion in 2022, then decreased by 15.14% to $1.1 billion in 2023, then grew by 7.17% to $1.2 billion in 2024, then dropped by 13.76% to $1.1 billion in 2025.
  • The last three reported values for Assets Average were $1.1 billion (Q4 2025), $1.0 billion (Q3 2025), and $1.1 billion (Q2 2025) per Business Quant data.